Search results for "Solid lipid nanoparticle"

showing 10 items of 38 documents

Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies

2009

The prospect of improved cancer therapy using Solid Lipid Nanoparticles (SLNs) as drug delivery system is promising. Sev- eral obstacles frequently encountered with anticancer compounds, such as poor drug solubility, are overcome by delivering them using SLN. Moreover, the intravenous administration of drugs into SLNs can potentially enhance drug blood circulation time and improve drug per- formance by inducing accumulation into tumours by enhanced permeability and retention (EPR) effect. This paper deals with the devel- opment of SLN containing nimesulide, a non-steroidal anti-inflammatory drug with antitumour effect and low solubility in water. Here, SLNs carrying nimesulide were prepared…

DrugMaterials sciencemedia_common.quotation_subjectsolid lipid nanoparticles nimesulide drug deliveryBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringPharmacologyIn vitroSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSolid lipid nanoparticleDrug deliveryZeta potentialmedicineSolubilityCytotoxicityBiotechnologymedia_commonNimesulidemedicine.drugCurrent Nanoscience
researchProduct

Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity.

2005

Solid lipid nanoparticles (SLNs) containing tamoxifen, a nons- teroidal antiestrogen used in breast cancer therapy, were prepared by microemulsion and precipitation techniques. Tamoxifen loaded SLNs seem to have dimensional properties useful for parenteral administration, and in vitro plasmatic drug release studies demon- strated that these systems are able to give a prolonged release of the drug in the intact form. Preliminary study of antiproliferative ac- tivity in vitro, carried out on MCF-7 cell line (human breast cancer cells), demonstrated that SLNs, containing tamoxifen showed an antitumoral activity comparable to free drug. The results of char- acterization studies and of in vitro …

DrugOctanolsMaterials scienceTime FactorsAntineoplastic Agents Hormonalmedia_common.quotation_subjectPharmaceutical SciencePharmacologyColloidal Drug Delivery Systems Solid Lipid Nanoparticles (SLNs) TamoxifenBreast cancerDrug StabilityCell Line TumorSolid lipid nanoparticlemedicineHumansParticle Sizeskin and connective tissue diseasesmedia_commonCell ProliferationDrug CarriersWaterGeneral MedicineHydrogen-Ion Concentrationmedicine.diseaseAntiestrogenLipidsIn vitroNanostructuresbody regionsTamoxifenSolubilityDelayed-Action PreparationsCancer cellDrug carrierTamoxifenmedicine.drugDrug delivery
researchProduct

Nanoparticle formulations as recrystallization inhibitors in transdermal patches

2020

Abstract Drug crystallization in transdermal patches is still a major challenge, confronting the formulation development of topical drug delivery systems. Encapsulation of drugs into nanoparticles is proposed here as a promising tool for regulating drug crystallization in transdermal patches. The degree of recrystallization and transdermal permeation of ibuprofen and hydrocortisone loaded in polymeric and lipid nanoparticles from matrix-type transdermal patches were investigated. Ethyl cellulose (EC4), poly (lactide-co-glycolic acid) (PLGA) and polycaprolactone (PCL) were employed for polymeric nanoparticle preparations; while medium chain triglyceride (MCT) and witepsol were used for the p…

HydrocortisoneSwinePolyestersSkin AbsorptionTransdermal PatchPharmaceutical ScienceNanoparticleIbuprofen02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePolylactic Acid-Polyglycolic Acid CopolymerEthyl celluloseSolid lipid nanoparticlemedicineAnimalsCelluloseTriglyceridesSkinTransdermalDrug CarriersChemistry021001 nanoscience & nanotechnologyIbuprofenDrug LiberationPLGAChemical engineeringPolycaprolactoneNanoparticlesNanocarriersCrystallization0210 nano-technologymedicine.drugInternational Journal of Pharmaceutics
researchProduct

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

2005

Various particle sizes of spironolactone as a model low solubility drug were formulated to yield micro-and nanosuspensions of the type solid lipid nanoparticles and DissoCubes. Seven oral and one i.v. formulations were tested in an in vivo pharmacokinetic study in rats with the aim of characterizing the bioavailability of spironolactone on the basis of its metabolites canrenone and 7-alpha-thiomethylspirolactone. In addition, a dose escalation study was carried out using nonmicronized spironolactone suspension as well as a nanosuspension type DissoCubes. On the basis of AUC as well as Cmax ratios, three groups of formulations were distinguished. The biggest improvement was seen with a solid…

MaleChemistry PharmaceuticalCmaxAdministration OralBiological AvailabilityPharmaceutical ScienceSpironolactonePharmacologyDrug Delivery SystemsPharmacokineticsPulmonary surfactantOral administrationDrug DiscoverySolid lipid nanoparticlemedicineAnimalsCanrenoneRats WistarSolubilityDiureticsPharmacologyChemistryOrganic ChemistryRatsBioavailabilityArea Under Curvemedicine.drugDrug Development and Industrial Pharmacy
researchProduct

BRAIN-TARGETED SOLID LIPID NANOPARTICLES CONTAINING RILUZOLE: PREPARATION, CHARACTERIZATION AND BIODISTRIBUTION

2009

Aim: Developments within nanomedicine have revealed a great potential for drug delivery to the brain. In this study nanoparticulate systems as drug carriers for riluzole, with sufficiently high loading capacity and small particle size, were prepared to a reach therapeutic drug level in the brain. Materials & method: Solid lipid nanoparticles containing riluzole have great potential as drug-delivery systems for amyotrophic lateral sclerosis and were produced by using the warm oil-in-water microemulsion technique. The resulting systems obtained were approximately 88 nm in size and negatively charged. Drug-release profiles demonstrated that a drug release was dependent on medium pH. Biodi…

Maleamyotrophic lateral sclerosisBiodistributionMaterials scienceSOLID LIPID NANOPARTICLES BRAIN TARGETING RILUZOLEBiomedical EngineeringDrug delivery to the brainMedicine (miscellaneous)NanoparticleBioengineeringDevelopmentPharmacologyRats Sprague-DawleyPlasmaDrug StabilitySolid lipid nanoparticlemedicineAnimalsHumansGeneral Materials ScienceParticle Sizebiodistributionmodified releaseDrug CarriersRiluzoleBrainLipidsRiluzoleRatssolid lipid nanoparticlesNeuroprotective AgentsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanomedicineNanoparticlesParticle sizeDrug carriermedicine.drug
researchProduct

Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimers Disease: Preparation, Characterization and Cytotoxicity Studies

2009

Materials sciencesolid lipid nanoparticles ferulic acid drug deliveryBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringFerulic acidchemistry.chemical_compoundchemistryBiochemistrySolid lipid nanoparticleDrug deliveryCytotoxicityBiotechnologyCurrent Nanoscience
researchProduct

EMPLOYMENT OF CATIONIC SOLID-LIPID NANOPARTICLES AS RNA CARRIERS

2007

Gene transfer represents an important advance in the treatment of both genetic and acquired diseases. In this article, the suitability of cationically modified solid-lipid nanoparticles (SLN) as a nonviral vector for gene delivery was investigated, in order to obtain stable materials able to condense RNA. Cationic SLN were produced by microemulsion using Compritol ATO 888 as matrix lipid, Pluronic F68 as tenside, and dimethyldioctadecylammonium bromide (DDAB) as cationic lipid. The resulting particles were approximately 100 nm in size and showed a highly positive surface charge (+41 mV) in water. Size and shape were further characterized by scanning electron microscopy (SEM) measurements. M…

MicroinjectionsCell SurvivalBiomedical EngineeringPharmaceutical ScienceNanoparticleBioengineeringNanotechnologyElectrophoretic Mobility Shift AssayPoloxamerGene deliveryTransfectionParacentrotus lividusCationsSolid lipid nanoparticleAnimalsNanotechnologyeducationcationic solid lipid nanoparticles gene deliveryOvumPharmacologyeducation.field_of_studyDrug CarriersbiologyChemistryOrganic ChemistryFatty AcidsCationic polymerizationRNAMembrane ProteinsTransfectionbiology.organism_classificationLipidsQuaternary Ammonium CompoundsSea UrchinsBiophysicsMicroscopy Electron ScanningNanoparticlesRNAEmulsionsDimethyldioctadecylammonium bromideBiotechnology
researchProduct

Solid lipid nanoparticles from amphiphilic calixpyrroles

2016

Abstract Hypothesis Macrocyclic amphiphiles form interesting self-assembling structures, including solid lipid nanoparticles, which have potential applications in drug encapsulation. Aryl-extended calixpyrroles, which act as anion binding hosts, are expected to form solid lipid nanoparticles, even though the alkyl chains have unusual perpendicular geometry with respect to the hydrophilic head group. The preparation conditions and the alkyl chain length should affect the size and stability of the particles. Experiments Solid lipid nanoparticles of two aryl-extended calixpyrroles with resorcinol walls and either meso-dodecyl or meso-methyl alkyl chains were compared. Ethanolic solutions of th…

Nanoparticleamphiphilesolid lipid nanoparticle02 engineering and technology010402 general chemistry01 natural sciencesBiomaterialszeta potentialColloid and Surface ChemistryDynamic light scatteringSolid lipid nanoparticleZeta potentialnanoparticle tracking analysisOrganic chemistrySurface chargeAnion bindingcalixpyrroleta116Alkylchemistry.chemical_classificationdynamic light scattering021001 nanoscience & nanotechnology540104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryChemical engineeringParticle size0210 nano-technologymacrocycle
researchProduct

Naringenin Nano-Delivery Systems and Their Therapeutic Applications

2021

Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nano…

Naringeninnatural productsnaringeninlcsh:RS1-441Pharmaceutical ScienceReview02 engineering and technologyPharmacologylcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalSolid lipid nanoparticleflavonoidnutraceuticalsLiposomeChemistryfood and beverages021001 nanoscience & nanotechnologynanomedicineBioavailabilityantioxidants030220 oncology & carcinogenesisdrug deliveryDrug deliveryNanomedicinenanoparticlesNanocarriersbioavailability0210 nano-technologyPharmaceutics
researchProduct

Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2

2011

Maria Luisa Bondì1,*, Giovanna Montana2,*, Emanuela Fabiola Craparo3, Roberto Di Gesù3, Gaetano Giammona3, Angela Bonura2, Paolo Colombo21Istituto per lo Studio dei Materiali Nanostrutturati, 2Istituto di Biomedicina ed Immunologia Molecolare, Consiglio Nazionale delle Ricerche, 3Laboratory of Biocompatible Polymers, Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari Stembio, Università di Palermo, Palermo, Italy *These authors contributed equally to this workAbstract: Parietaria pollen is one of the major causes of allergic reaction in southern Europe, affecting about 30% of all allergic patients in this area. Specific immunotherapy is the only…

ParietariaMembrane lipidsBiophysicsPharmaceutical Sciencerecombinant allergensEnzyme-Linked Immunosorbent AssayBioengineeringmedicine.disease_causelaw.inventionBiomaterialsMembrane LipidsAllergenlawInternational Journal of NanomedicineParietaria judaica (Par j)Drug DiscoverySolid lipid nanoparticlemedicineHumansParticle SizePyrophosphatasesOriginal ResearchPlant ProteinsDrug Carriersallergic rhinitisbiologyPhosphoric Diester HydrolasesChemistryOrganic ChemistryRhinitis Allergic SeasonalGeneral MedicineAllergensbiology.organism_classificationMolecular biologyRecombinant ProteinsBasophilssolid lipid nanoparticlesBiochemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativodrug deliveryDrug deliveryParietaria judaicaRecombinant DNAsolid lipid nanoparticles Parietaria judaica (Par j) drug delivery recombinant allergens specific immunotherapy allergic rhinitis.NanoparticlesEmulsionsImmunotherapyDrug carrierspecific immunotherapyInternational Journal of Nanomedicine
researchProduct